CompletedPhase 1

Oral Bioavailability of GLPG0555 in Different Solid Formulations

Belgium12 participantsStarted 2011-01

Plain-language summary

The purpose of the study is to compare the pharmacokinetics of a solid capsule formulation of GLPG0555 with a nanosuspension, and to assess safety and tolerability of a single dose of GLPG0555.

Who can participate

Age range18 Years – 50 Years

SexMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * healthy male * BMI between 18-30 kg/m², inclusive. Exclusion Criteria: * significantly abnormal platelet function or coagulopathy * smoking * drug or alcohol abuse

What they're measuring

Bioavailability of solid formulation

Timeframe: 72 hrs

Trial details

NCT IDNCT01278095

SponsorGalapagos NV

Sponsor typeINDUSTRY

Study typeINTERVENTIONAL

Primary completion2011-02

View on ClinicalTrials.gov More Healthy trials